Figure 2.
Figure 2. Steady-state plasma concentrations of the PI3Kδ inhibitor INCB040093. (A) Patients receiving multiple doses of INCB040093 monotherapy in Part 1. (B) Patients receiving multiple doses of INCB040093 combined with the JAK1 inhibitor itacitinib in Part 2. IC90, 90% inhibitory concentration; SE, standard error.

Steady-state plasma concentrations of the PI3Kδ inhibitor INCB040093. (A) Patients receiving multiple doses of INCB040093 monotherapy in Part 1. (B) Patients receiving multiple doses of INCB040093 combined with the JAK1 inhibitor itacitinib in Part 2. IC90, 90% inhibitory concentration; SE, standard error.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal